Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00131456
Status:
COMPLETED
Last Update Posted:
2019-04-24
First Post:
2005-08-16
Brief Title:
Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1
Sponsor:
New York State Psychiatric Institute
Organization:
New York State Psychiatric Institute
Study Overview
Official Title:
Marijuana Addiction and Depression Venlafaxine Treatment
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
VEN
Brief Summary:
The purpose of this study is to determine if Venlafaxine Extended Release Ven-XR is effective in treating individuals with marijuana addiction and depression
Detailed Description:
Given that depression and marijuana addiction often occur together medications to treat individuals diagnosed with both conditions may be effective The purpose of this study is to determine the effectiveness of Ven-XR in treating individuals diagnosed with depression and marijuana addiction
During this twelve-week double-blind placebo-controlled study study visits will occur twice each week During study visits participants will receive either placebo or medication and provide a urine sample for drug screening Blood tests will be collected each month and women must take pregnancy tests each month Throughout the study all participants will receive individualized psychotherapy sessions At each study visit participants will be given 5 to cover transportation costs
During this twelve-week double-blind placebo-controlled study study visits will occur twice each week During study visits participants will receive either placebo or medication and provide a urine sample for drug screening Blood tests will be collected each month and women must take pregnancy tests each month Throughout the study all participants will receive individualized psychotherapy sessions At each study visit participants will be given 5 to cover transportation costs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R01DA015451 | NIH | None | httpsreporternihgovquickSearchR01DA015451 |